Skip to main content

Table 3 Interpretation of DPS data and proposed ATT treatment decisions in context of continuous adherence

From: Formative acceptance of ingestible biosensors to measure adherence to TB medications

Variable

n (%)

Interpretation of adherence category

 Fully adherent

40 (80%)

 Partially/suboptimally adherent

10 (20%)

 Nonadherent

0 (0%)

ATT treatment decisions informed by DPS data

 No action (continued monitoring)

27 (54%)

 Reinforce adherence through counseling at clinical visit

16 (32%)

 Phone call to patient

8 (16%)

 Health care worker visit

6 (12%)

 Transition to DOTS

1 (2%)

 Test for multidrug resistant TB (MDR-TB)

1 (2%)

 Other

1 (2%)